Julie Vose MD, MBA

Dr. Julie Vose is an oncology and hematology physician and the director of the Lymphoma Research Group. Her personal research involves treating patients with non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Her clinical areas of focus include chemotherapy, immunotherapy, cellular therapy, and pathway-directed agents for treatment and clinical trial research.

Dr. Vose has been involved in oncology and hematology for more than 30 years, and she had the honor of serving as the President of the American Society of Clinical Oncology (ASCO) in 2016. She has published more than 400 manuscripts on the treatment of patients with lymphoma or related entities.